PharVision Advisers’s Arcos Dorados Holdings ARCO Stock Holding History

PharVision Advisers’s Portfolio ARCO Stock Details ARCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$95.1K	Buy	13,294 +2,529	+23%	+$20.3K	3.86%	8
2026 Q2	$86.8K	Sell	10,765 -1,970	-15%	-$17K	1.64%	28
2026 Q1	$105K	Sell	12,735 -29,095	-70%	-$236K	1.07%	45
2025 Q4	$307K	Buy	41,830 +1,976	+5%	+$14.2K	0.16%	258
2025 Q3	$269K	Buy	+39,854	New	+$283K	0.15%	291
2025 Q1	–	Sell	-48,055	Closed	-$350K	–	280
2024 Q4	$350K	Buy	+48,055	New	+$412K	0.3%	106

Other funds holding ARCO

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Moerus Capital Management New York $222M AUM 28.89% 1-Year Est. Return

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Causeway Capital Management Los Angeles, California $8.9B AUM 6.03% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Managed Asset Portfolios Rochester, Michigan $902M AUM 36.95% 1-Year Est. Return

PharVision Advisers's ARCO Position: Q3 2026 in Review

PharVision Advisers increased its Arcos Dorados Holdings (ARCO) stake by 23% in Q3 2026, buying an estimated $20.3K and bringing the position to 13,294 shares worth $95.1K. The position accounts for 3.86% of the portfolio, ranked #8.

PharVision Advisers first reported a position in ARCO in Q4 2024 and has held it in 6 quarters since. The position peaked at $350K in Q4 2024. 134 funds tracked by Wall St. Rank hold ARCO as of Q3 2026.

PharVision Advisers held 13,294 shares of Arcos Dorados Holdings worth $95.1K as of Q3 2026.
PharVision Advisers bought 2,529 Arcos Dorados Holdings shares in Q3 2026, an estimated $20.3K.
Arcos Dorados Holdings made up 3.86% of PharVision Advisers's portfolio in Q3 2026, its #8 holding.
PharVision Advisers first reported a position in Arcos Dorados Holdings in Q4 2024 and has held it in 6 quarters since.
PharVision Advisers's Arcos Dorados Holdings position peaked at $350K in Q4 2024.
134 funds tracked by Wall St. Rank held Arcos Dorados Holdings as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.